Orthokeratology Lens Market Size, Share & Industry Analysis, By Type (Overnight Ortho-K Lens and Daytime Ortho-K Lens), By Age Group (Children and Adults), By Application (Myopia, Astigmatism, and Others), By End-user (Optometrist Offices, Hospitals & Ophthalmology Clinics, and Others), and Regional Forecast, 2024-2032

The global orthokeratology lens market size was valued at USD 869.6 million in 2023. The market is projected to grow from USD 990.6 million in 2024 to USD 3,987.3 million by 2032, exhibiting a CAGR of 19.0% during the forecast period. Asia Pacific dominated the global orthokeratology lens market with a market share of 53.83% in 2023.

Orthokeratology Lens (OK Lens) is a special gas permeable lens designed for corneal reshaping and is suitable for all age groups. These lenses can be worn overnight and allow patients to be free from spectacles and contact lenses during the daytime. They correct refractive errors, such as myopia, astigmatism, and hyperopia. Several latest studies show that orthokeratology treatment is one of the most effective ways to slow down myopia progression in children. Some healthcare providers in certain countries also prescribe these lenses as daytime ortho-K lenses.

The increasing prevalence of refractive errors, such as myopia, astigmatism, and hyperopia among the global population and rising awareness regarding the benefits of these lenses in their treatment are some of the major factors expected to fuel the demand for this lens.

• As per a 2019 article published by the U.S. National Eye Institute, approximately 42% of the U.S. population suffer from myopia.


• Similarly, according to an article published by the Australian National University, the prevalence of myopia in East and Southeast Asia is around 80-90% in young adults.

The COVID-19 pandemic negatively affected the market growth. The reduced number of patient visits to optometrist clinics and hospitals for eye check-ups due to the lockdown restrictions was one of the primary reasons for the lower demand for these lenses among the population. The major market players also reported a decline in their 2020 revenue due to decreased demand for lenses and sales of the products globally.

However, the prevalence of myopia significantly increased after the COVID-19 pandemic, especially in children. Some of the major factors attributable to this rise were: increased screen time at home and decreased time spent outdoors. The market players recovered their revenues in 2021 and witnessed growth due to the resumption of operations and increased demand for lenses globally. Thus, the growing patient population and resumption of ophthalmologic practices and services are expected to augment the market growth in the coming years.

Orthokeratology Lens Market Trends

Shifting Consumer Preference for Non-Surgical Procedures for Vision Correction to Propel Market Growth

Various vision correction surgeries are available for refractive errors, such as myopia and astigmatism, including LASIK surgeries, Photorefractive Keratectomy (PRK) surgeries, refractive lens exchange, and others.

However, some of the side effects associated with these surgeries, such as dry eye, itching, distorted vision, glare, and halos around lights at night have reduced the demand for these procedures among the population.

• For instance, according to a 2020 article, 20-40% of the patients who undergo a surgical procedure to correct their vision suffer from dry eye and itching after the surgery. Moreover, about 20% of people who have LASIK have difficulty with contrast and struggle with glare and halos around light at night.

Additionally, limited options available for refractive error correction among children is one of the important factors leading to shifting preference toward OK lenses among children. Moreover, eliminating the need to wear spectacles and contact lenses during daytime is another contributing factor to the rising adoption of these lenses among children.

Furthermore, technological advancements in developing orthokeratology lenses are associated with comfort and fitting. Several industry players are utilizing high-quality materials to develop OK lenses to provide comfort to users. Also, growing awareness among eye care professionals and consumers about the benefits of OK lenses in myopia is another factor contributing to the adoption of these lenses among children.

• For instance, in September 2023, AccuLens introduced its newest OK lens, NewVision SC, a corneoscleral OrthoK design, which received U.S. FDA approvals. This lens is made exclusively from Contamac Infinite (tisilfocon A) material and features a large diameter design for enhanced wear-time flexibility and comfort.


• Similarly, in September 2021, Scotlens, one of the specialty contact lens manufacturers, collaborated with Avizor to launch a new unboxing experience for ortho-K lenses to increase awareness about the lenses.

Thus, the increasing number of product approvals and launches by major market players, rising technological advancements, and awareness of the benefits of these lenses are expected to increase the growth opportunities for non-surgical procedures for refractive error correction.

Orthokeratology Lens Market Growth Factors

Growing Prevalence of Refractive Errors Among Population and Advantages of OK Lens to Fuel Market Growth

The global prevalence of refractive errors, such as myopia, astigmatism, and hyperopia among the population is rising at a significant pace, especially after the COVID-19 pandemic. The increased screen time among the population is one of the major factors responsible for the growing prevalence of myopia.

• According to a 2020 article published by BMC Ophthalmology, myopia prevalence in Asia was around 60% and in Europe around 40%. The total myopia population is projected to reach around 4.8 billion by 2050.


• According to a 2021 article published by the Lancet Journal, there was a 50-70% increase in internet use during the COVID-19 pandemic. This factor is expected to increase the prevalence of refractive error globally.

In addition, there is a growing emphasis on proactive measures to prevent and address eye conditions, including myopia. Orthokeratology lenses are positioned as a proactive approach to myopia management, appealing to parents and individuals concerned about long-term eye health.

Several treatment options are available for a patient's refractive error correction, such as LASIK surgeries, spectacles, and others. However, these alternative treatments do not slow down the progression of myopia. Several latest studies show that orthokeratology treatment can slow down myopia progression in children when started at an early stage.

• According to a 2020 article published by Annals of Eye Science, clinical trials showed a reduction in axial eye elongation by around 40-45% in progressively myopic children.

Thus, the increasing benefits of these lenses and growing prevalence rate of refractive errors and diagnoses among the population are expected to fuel the market.

Increasing R&D Investments in Ortho-K Lens to Propel Market Growth

The increasing demand for OK lenses among the population owing to their benefits and efficacy is prompting major market players to shift their focus toward these products. The rising efforts by market players are leading to a higher number of product launches and regulatory approvals to cater to the demand for these lenses.

• For instance, in May 2023, Menicon Co., Ltd. announced the launch of the orthokeratology lens Menicon Z Night in China.


• In May 2021, the Cooper Companies Inc. received the CE approval from the European Union for its Dreamlite OK Lens to slow myopia progression among children and young adults.

Additionally, a growing number of strategic acquisitions and partnerships among the major players is leading to a rising number of product launches to cater to the population's demand.

• In January 2022, Johnson & Johnson Vision Care, Inc. launched the ACUVUE Abiliti overnight therapeutic lenses to help children with myopia management in Singapore.

Thus, the increasing research and development activities by the major market players and rising technological advancements to widen their application area are expected to drive market growth during the forecast period.

RESTRAINING FACTORS

High Cost Associated with Treatment and Inadequate Reimbursement Policies to Hamper Market Growth

The cost of orthokeratology varies based on the optometrist, type and level of refractive error, which means a higher level of refractive error may require more than one fitted lens, and several other factors. The direct cost associated with orthokeratology includes the lens and fitting costs. The lack of reimbursement policies for orthokeratology treatment and high cost of fitting and post-fitting care of OK lens are some of the factors that might limit the orthokeratology lens market growth during the forecast period.

• As per the data provided by the NVISION Eye Centers in August 2023, the price range for OK lenses varies from USD 600 to USD 1,200 per eye, with more intricate cases potentially costing USD 2,000 or higher per eye. These figures exclude expenses for replacement lenses, follow-up appointments with the doctor, and lens solutions.


• For instance, according to a 2021 article published by CareCredit, the treatment cost can range from USD 1,200 to USD 2,000 with difficult cases, with a higher level of error even costing up to USD 4,000. Also, the additional costs, including those of replacement lenses, lens solution, follow-up examination & consultation charges, and others range from USD 300 to USD 500 per year.

Furthermore, orthokeratology treatment is considered an elective surgery as the treatment is usually not covered completely under reimbursement policies. This factor increases the financial burden on the patient due to higher out-of-pocket expenditure.

• As per a 2020 article published by Eyecare Concepts, the Myopic Clinic, there is no Medicare coverage for complete orthokeratology fitting and usually only covers general eye tests and eye health consultations.

Thus, higher costs associated with these lenses and inadequate reimbursement policies are expected to restrict the adoption of these lenses among the population.

Orthokeratology Lens Market Segmentation Analysis

By Type Analysis

Overnight Ortho-K Lens Grew in Demand Owing to Rising Technological Advancements and Lucrative Benefits

On the basis of type, the market is segmented into overnight ortho-K lens and daytime ortho-K lens.

The overnight ortho-K lens segment dominated the global market in terms of value (USD million) and volume (1,000 Pairs) in 2023. Rising advancements in the material used in these lenses are leading to their increasing use among the population. These lenses are worn at night while sleeping, increasing comfort and eliminating the need to wear eyeglasses or contact lenses during the daytime.

Additionally, the rising efforts by market players to introduce innovative products are expected to increase the segment’s market share during the forecast period. For instance, in May 2021, Euclid Vision Corporation launched Euclid MAX Overnight Ortho-K Lens in the U.S. for children and adult patients with progressive myopia.

By Age Group Analysis

Children Segment to Lead Market Backed by its Effectiveness to Cure Kids Suffering from Myopia

On the basis of age group, the market is segmented into children and adults.

The children segment is expected to dominate the market in coming years. The increasing prevalence of myopia, astigmatism, and other refractive errors in children, especially after the COVID-19 pandemic is one of the major factors contributing to the rising adoption of these lenses in this age group. Additionally, the increasing number of clinical studies demonstrating the benefits of orthokeratology lenses in slowing down myopia progression in children at an early stage is anticipated to increase the use of these lenses in this age group.

• According to a 2021 clinical study result published by the U.S. National Institute of Health, there was around 35-50% decline in myopia progression in the children group wearing orthokeratology lenses compared to the group wearing spectacles and contact lenses.

Thus, when coupled with limited options for vision correction treatment in children, these factors are anticipated to propel the segment’s growth during the forecast period.

Similarly, the increasing prevalence of myopia, astigmatism, and other refractive errors in the adult population and growing awareness regarding the benefits of these lenses, such as increased comfort, safety, and others are fueling the adoption of these lenses among the adult population.

Moreover, the increasing approvals and launches of new products for correcting refractive errors in adults are also some of the factors contributing to the rising adoption of this lens among adults.

• In May 2021, the Cooper Companies Inc. received the EU approval for its Procornea DreamLite overnight ortho-K lens for slowing the myopia progression in children and young adults.

These factors mentioned above and a rising number of emerging players in the market are expected to spur the market growth during the forecast period.

By Application Analysis

Myopia Segment to Lead Market Due to Growing Prevalence of Myopia Among People

Based on application, the market is segmented into myopia, astigmatism, and others.

The myopia segment dominated the market in 2023. The rising prevalence of myopia among children and the geriatric population globally and patient's preference for non-invasive procedures over refractive surgeries are some of the major factors contributing to the segment's growth in terms of value (USD million) and volume (1,000 pairs). Additionally, the increasing efforts by international organizations and market players to increase awareness regarding myopia among the population will favor the segment’s growth during the forecast period.

• In January 2022, Euclid Vision Corporation partnered with Global Specialty Lens Symposium to create awareness regarding myopia and educate Eye Care Providers (ECPs) on advanced orthokeratology and proactive myopia management.


• Similarly, in October 2023, CooperVision launched a new education initiative in the U.S. titled "Take Control: Myopia & You" to raise awareness about the condition and urge parents to prioritize eye exams for their young children.

The astigmatism segment is expected to register a significant CAGR during the forecast period owing to several factors, such as the growing prevalence of the condition among the population, increasing applications of this lens in treatment of astigmatism, and others. Also, the growing adoption of these lenses among people with astigmatism is expected to drive the segment’s growth.

• For instance, in February 2022, according to Nvision Eye Centers, one in every three people suffered from astigmatism in the U.S.

The growing research and development activities to study the efficiency of these lenses in the management of hyperopia, presbyopia, and others, along with the growing prevalence of these conditions globally, is anticipated to augment the segment's growth during the forecast period.

By End-user Analysis

Optometrist Offices Segment to Dominate Market Due to Rising Number of Prescriptions for Ortho-K Lens

Based on end-user, the market is segmented into optometrist offices, hospitals & ophthalmology clinics, and others.

The growing technological advancements in the diagnosis and treatment of refractive errors are resulting in higher adoption of these lenses among optometrists. This is one of the most important factors stimulating the growth of the optometrist offices segment. Also, the rising number of partnerships among market players and optometrists will contribute to the segment's growth.

• For instance, in July 2022, Euclid Vision Corporation announced an interactive, web-based customer portal to practice efficiency and optimize Euclid orthokeratology fits. This will help optometrists diagnose refractive errors, such as myopia, hyperopia, and others.

The increasing number of hospitals & ophthalmology clinics rendering lens fitting services and other refractive error correction treatments is a primary factor that will favor the segment's growth during the forecast period.

REGIONAL INSIGHTS

Regionally, the market is studied across Asia Pacific, Europe, North America, and the rest of the world.

Asia Pacific was valued at USD 468.1 million in 2023 and dominated the global orthokeratology lens market share in terms of value (USD million) and volume (1,000 pairs). The region is projected to register the highest CAGR during the forecast period. The increasing use of these lenses in China, Japan, and other countries owing to rising awareness of these lenses is a primary factor contributing to the regional market’s growth. Moreover, growing initiatives by governments to increase awareness regarding the benefits of this lens in the treatment of refractive errors are also contributing to the regional market's growth.

• For instance, in June 2018, the Guide to Myopia Prevention and Control released by the National Health Commission of China listed OK Lens as a corrective measure for myopia prevention and control.

In North America, the market is expected to grow rapidly during the forecast period owing to the rising number of mergers and acquisitions among market players to expand their product portfolio and geographical presence.

• For instance, in August 2020, The Cooper Companies Inc. acquired CE GP Specialists, one of the leading orthokeratology contact lens manufacturers and distributors, to expand its product portfolio to cater to the demands of the myopic population.

Moreover, the increasing number of prescriptions of these lenses by healthcare providers in European countries is one of the major contributing factors fueling the regional market’s growth.

• According to a 2020 article published by Elsevier, there were around 6-6.5% of orthokeratology lens prescriptions in the Netherlands in 2018. The high proportion of these lens fittings in the country was due to rising awareness regarding the treatment, an increasing number of laboratories customizing the lens design, and other factors.

Thus, these factors, along with the rising prevalence of myopia, astigmatism, and increasing adoption of orthokeratology lenses, are responsible for the market's growth in emerging regions, such as Latin America and the Middle East & Africa.

Key Industry Players

The Cooper Companies Inc. Leads Market with a Strong Focus on Increasing its Product Portfolio

The global market is consolidated, with a few major players, including The Cooper Companies Inc., Menicon Co. Ltd., Bausch Health Companies Inc., and Euclid Vision Corporation, among others, holding the market's maximum share.

The market players' focus on catering to the rising demand for these lenses is increasing owing to the growing prevalence of refractive errors globally. Additionally, the implementation of strategies by key players to expand their product portfolio and geographical presence is another factor contributing to the market's growth.

The Cooper Companies Inc. remained the market leader in terms of share in 2023 owing to a strong product portfolio and robust efforts to expand the geographical presence with strategic mergers and acquisitions.

• In June 2022, the Cooper Companies Inc. acquired EnsEyes, one of the leading suppliers of OK Lens and scleral lens in Europe’s Nordic region, to expand its specialty contact lens business.

Similarly, market players, such as Menicon Co., Ltd., Euclid Vision Corporation, Bausch Health Companies Inc., and others, are taking various efforts to expand their product portfolio by introducing innovative products. This will help them cater to the growing demand for these lenses among the patient population, thereby expanding their market share in the future.

• In April 2022, Johnson & Johnson Vision Care, Inc. launched the ACUVUE ABILITI brand to address the growing prevalence of myopia and increase the penetration of orthokeratology in Hong Kong.

Thus, the growing demand for these lenses among the population globally, along with increasing technological advancements and innovation in products, is anticipated to increase the market share of the emerging players.

LIST OF TOP ORTHOKERATOLOGY LENS COMPANIES:

• The Cooper Companies Inc. (U.S.) 


• Menicon Co., Ltd. (Japan)


• Euclid Vision Corporation (U.S.)


• Bausch & Lomb Incorporated (Canada)


• Johnson & Johnson Services, Inc. (U.S.)


• Brighten Optix.Co (China)


• TruForm Optics Inc. (U.S.)


• Art Optical Contact Lens, Inc. (U.S.)

KEY INDUSTRY DEVELOPMENTS

• September 2022 - Johnson & Johnson Services Inc. received the U.S. FDA approval for its ACUVUE Abiliti Overnight Therapeutic Lenses for an expanded range of up to 6.00 diopters, which was previously up to 4.00 diopters.


• April 2022 – Euclid Vision Corporation acquired Visionary Optics to enhance its product portfolio in the specialty contact lens segment.


• November 2021 – Johnson & Johnson Services Inc. received the U.S. FDA approval for its ACUVUE Abiliti Overnight Therapeutic Lenses for myopia management.


• April 2021 - Menicon Co., Ltd. collaborated with Johnson & Johnson Vision to launch therapeutic lens-related products and services to combat myopia in children.


• August 2020 – The Cooper Companies Inc. acquired C&E GP Specialists Inc., one of the leading contact lens manufacturers and distributors, to expand CooperVision’s specialty eye care business and address the increasing severity and prevalence of myopia.

REPORT COVERAGE

The research report offers a detailed market analysis and overview. It focuses on key aspects, such as competitive landscape, product type, and indication. Besides this, it offers insights into the market trends, market dynamics, and other key insights. In addition to the factors mentioned above, the report encompasses several factors that have contributed to the market's growth in recent years.

Report Scope & Segmentation

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Unit	Value (USD million) and Volume (1,000 Pairs)
Growth Rate	CAGR of 19.0% from 2024-2032
Segmentation	By Type Overnight Ortho-K Lens Daytime Ortho-K Lens
By Age Group Children Adults
By Application Myopia Astigmatism Others
By End-user Optometrist Offices Hospitals & Ophthalmology Clinics Others
By Region North America (By Type, Age Group, Application, End-user, and Country) U.S. Canada Europe (By Type, Age Group, Application, End-user, and Country) U.K. Germany France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Type, Age Group, Application, End-user, and Country/Sub-Region) Japan China India Australia Southeast Asia Rest of Asia Pacific Rest of the World (By Type, Age Group, Application, and End-user)